• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Menopausal Disorders - Pipeline Review, H1 2012 Product Image

Menopausal Disorders - Pipeline Review, H1 2012

  • ID: 2092668
  • March 2012
  • 155 pages
  • Global Markets Direct

Menopausal Disorders – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, 'Menopausal Disorders - Pipeline Review, H1 2012', provides an overview of the Menopausal Disorders therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Menopausal Disorders. 'Menopausal Disorders - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Menopausal Disorders.
- A review of the Menopausal Disorders products under development by companies and READ MORE >



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Menopausal Disorders Overview
Therapeutics Development
An Overview of Pipeline Products for Menopausal Disorders
Menopausal Disorders Therapeutics under Development by Companies
Menopausal Disorders Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Menopausal Disorders Therapeutics – Products under Development by Companies
Menopausal Disorders Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in Menopausal Disorders Therapeutics Development
Amgen Inc.
Merck & Co., Inc.
Ablynx
Arkopharma SA
Chiesi Farmaceutici SpA
Depomed, Inc.
Noven Pharmaceuticals, Inc.
Pfizer Inc.
Zosano Pharma, Inc.
Osteologix, Inc.
Paladin Labs Inc.
Bionovo, Inc.
Unigene Laboratories, Inc.
Acceleron Pharma, Inc.
Pantarhei Bioscience BV
EffRx, Inc.
Radius Health, Inc.
Meditrina Pharmaceuticals, Inc.
DSM Nutritional Products AG
Lipocine Inc.
Tarsa Therapeutics, Inc.
Pherin Pharmaceuticals, Inc.
Ausio Pharmaceuticals, LLC
Menopausal Disorders – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
AMG 785 - Drug Profile
Odanacatib - Drug Profile
Serada - Drug Profile
Mesafem - Drug Profile
Sotatercept - Drug Profile
RAD1901 - Drug Profile
Steovess - Drug Profile
Estetrol - Drug Profile
Ellavie - Drug Profile
Estradiol + Testosterone Gel - Drug Profile
Menerba - Drug Profile
Seala - Drug Profile
NB S101 - Drug Profile
PTH Analogs Oral - Drug Profile
OSTORA - Drug Profile
Aprela - Drug Profile
Femathina - Drug Profile
ALX-0141 - Drug Profile
AUS-131 - Drug Profile
Parathyroid Hormone-Related Protein (1-36) - Drug Profile
Fablyn - Drug Profile
CHF4227 - Drug Profile
Denosumab + Teriparatide - Drug Profile
ZP-PTH - Drug Profile
Zosano PTH - Drug Profile
Acupuncture + Gabapentin - Drug Profile
Bonviva - Drug Profile
Actonel - Drug Profile
Fosamax - Drug Profile
Cyclophosphamide + Goserelin - Drug Profile
Pregabalin - Drug Profile
Megestrol Acetate - Drug Profile
Pristiq - Drug Profile
Black Cohosh - Drug Profile
Citalopram hydrobromide - Drug Profile
PF-04427429 - Drug Profile
CDB-2914 - Drug Profile
Prometrium - Drug Profile
Estradiol + Progesterone - Drug Profile
Estradiol + Estriol + Progesterone - Drug Profile
Estradiol + Medroxyprogesterone acetate - Drug Profile
Danggui Buxue Tang - Drug Profile
Estradiol - Drug Profile
BA058 - Drug Profile
Phyto Soya Vaginal Gel - Drug Profile
Denosumab + Alendronate - Drug Profile
PTH 1-34 + Fluoride - Drug Profile
PTH 1-34 - Drug Profile
Fluoride - Drug Profile
Ostora - Drug Profile
PH80-HF - Drug Profile
Nelfinavir + NRTIs + Estradiol + Medroxyprogesterone acetate - Drug Profile
Gabapentin - Drug Profile
LPCN 1002 - Drug Profile
Menopausal Disorders Therapeutics – Drug Profile Updates
Menopausal Disorders Therapeutics – Discontinued Products
Menopausal Disorders Therapeutics - Dormant Products
Menopausal Disorders – Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Menopausal Disorders, H1 2012
Products under Development for Menopausal Disorders – Comparative Analysis, H1 2012
Number of Products under Development by Companies, H1 2012
Number of Products under Development by Companies, H1 2012 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H1 2012
Comparative Analysis by Late Stage Development, H1 2012
Comparative Analysis by Mid Clinical Stage Development, H1 2012
Comparative Analysis by Early Clinical Stage Development, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Amgen Inc., H1 2012
Merck & Co., Inc., H1 2012
Ablynx, H1 2012
Arkopharma SA, H1 2012
Chiesi Farmaceutici SpA, H1 2012
Depomed, Inc., H1 2012
Noven Pharmaceuticals, Inc., H1 2012
Pfizer Inc., H1 2012
Zosano Pharma, Inc., H1 2012
Osteologix, Inc., H1 2012
Paladin Labs Inc., H1 2012
Bionovo, Inc., H1 2012
Unigene Laboratories, Inc., H1 2012
Acceleron Pharma, Inc., H1 2012
Pantarhei Bioscience BV, H1 2012
EffRx, Inc., H1 2012
Radius Health, Inc., H1 2012
Meditrina Pharmaceuticals, Inc., H1 2012
DSM Nutritional Products AG, H1 2012
Lipocine Inc., H1 2012
Tarsa Therapeutics, Inc., H1 2012
Pherin Pharmaceuticals, Inc., H1 2012
Ausio Pharmaceuticals, LLC, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Stage and Molecule Type, H1 2012
Menopausal Disorders Therapeutics – Drug Profile Updates
Menopausal Disorders Therapeutics – Discontinued Products
Menopausal Disorders Therapeutics – Dormant Products
Menopausal Disorders Therapeutics – Dormant Products (Contd..1)
Menopausal Disorders Therapeutics – Dormant Products (Contd..2)

List of Figures
Number of Products under Development for Menopausal Disorders, H1 2012
Products under Development for Menopausal Disorders – Comparative Analysis, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Late Stage Products, H1 2012
Mid Clinical Stage Products, H1 2012
Early Clinical Stage Products, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Route of Administration, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Molecule Type, H1 2012
Assessment by Stage and Molecule Type, H1 2012

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos